- Entry
- $4.37
- Now
- $4.92 +12.6%
- Target
- —
- Score
- —
**$PYPD – FDA just accepted the NDA with Priority Review + $15M milestone triggered. Short-term setup just got a lot hotter** PolyPid ($PYPD) just hit a major catalyst today (July 29): FDA accepted the NDA for D-PLEX₁₀₀ and granted **Priority Review**. PDUFA target action date is now **November 28, 2026** — roughly a full quarter earlier than the previous Q1 2027 guidance. FDA identified **no filing review issues**. This acceptance immediately triggers the second $15M milestone from the Azurity partnership, …
— ORIGINAL POST ·
$PYPD Today PolyPid Announces FDA Acceptance of NDA with Priority Review for D-PLEX₁₀₀
· r/pennystocks
· Jul 29, 2026